Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Schedule of Segment Information (Details)

v3.19.3
Segment Reporting - Schedule of Segment Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Net revenues - External $ 14,548,690 $ 3,088,216
(Loss) from operations (13,224,620) (16,076,107)
Depreciation and amortization 1,263,844 1,715,321
Capital expenditures 213,105 1,422,002
Total assets 14,199,300 6,290,794
Clinical Laboratory Operations [Member]    
Net revenues - External 131,014 2,210,318
(Loss) from operations (2,247,499) (4,672,768)
Depreciation and amortization 764,445 1,639,954
Capital expenditures
Total assets 271,426 1,503,520
Hospital Operations [Member]    
Net revenues - External 14,417,676 877,898
(Loss) from operations (6,434,538) (4,800,539)
Depreciation and amortization 498,352 73,985
Capital expenditures 213,105 1,422,002
Total assets 13,568,933 2,549,504
Corporate [Member]    
(Loss) from operations (4,542,583) (6,602,800)
Depreciation and amortization 1,047 1,382
Total assets 2,707,416 3,436,773
Assets of AMSG And HTS Classified as Held for Sale [Member]    
Total assets 152,171 255,566
Eliminations [Member]    
Total assets $ (2,500,646) $ (1,454,570)